Abstract:Poly(lactic-co-glycolic acid) (PLGA) is a widely utilized polymer for biomedical applications due to its biocompatibility and degradability in vivo. Traditional methods of fabrication of drug-loaded nanoparticles (NPs) employ the random sequence form of linear PLGA to yield non-crosslinked polymeric NPs that form when the polymer nanoprecipitates out of solution. Given the large-scale use of PLGA-based polymeric drug delivery systems to date, it is crucial to be able to control the ratio and sequence of lactic and glycolic components in the overall drug delivery system, which in turn can impact factors such as stability, drug loading, drug release and degradability. In this work, we present a novel PLGA-inspired NP polymerization technique, which allows the formation of NPs via the cross-linking of precisely sequenced short oligolactoglycolic acid dimethacrylates (OLGADMAs). Following the synthesis of a range of OLGADMAs we successfully generated a library of NPs via this rapid and surfactant-free nanopolymerization method, which permits the simultaneous NP formation and encapsulation of drugs such as dexamethasone. Our results indicate that NPs produced through this nanopolymerization technique with precisely controlled sequences exhibit heightened stability compared to conventionally sequenced and non-sequence controlled PLGA, as evidenced by minimal pH changes over a five-week span. This improved stability is attributed to simultaneous crosslinking and co-polymerization of the OLGADMAs. Moreover, the long-acting NPs demonstrated minimal cytotoxicity and uniform cellular uptake in vitro. We conclude that the ability to precisely regulate the sequence of short PLGA-inspired monomers and employ a unique in situ nanopolymerizing reaction results in exceptionally stable NPs for sustained drug delivery and opens exciting possibilities for the development of a range of long-lasting drug delivery systems with programmable structure and function.

PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery

Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying

Polymer-controlled core–shell nanoparticles: a novel strategy for sequential drug release

Vitamin E-Loaded PLA- and PLGA-Based Core-Shell Nanoparticles: Synthesis, Structure Optimization and Controlled Drug Release

Lipoyl Ester Terminated Star PLGA As a Simple and Smart Material for Controlled Drug Delivery Application

PLGA/polymeric liposome for targeted drug and gene co-delivery.

Dual drug release from core-shell nanoparticles with distinct release profiles.

Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug

Fabrication of Monodisperse Drug-Loaded Poly(lactic-Co-glycolic Acid)–chitosan Core-Shell Nanocomposites Via Pickering Emulsion

Preparation and Characterization of Zwitterionic Phospholipid Polymer-Coated Poly(lactic Acid) Nanoparticles

Poly(Lactic Acid)/Poly(Ethylene Glycol) Block Copolymer Based Shell or Core Cross-Linked Micelles for Controlled Release of Hydrophobic Drug

Study on the preparation and properties of R8 conjugated PLGA-lecithin-PEG core-shell nanoparticles in vitro

Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery

Long-lasting Cross-linked PLGA-Inspired Nanoparticles from One-pot Nanopolymerization of Precisely Sequenced Short Oligolactoglycolic Acid Dimethacrylates

Composite Core-Shell Microparticles from Microfluidics for Synergistic Drug Delivery

Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform

Fabrication of Core–shell Micro/nanoparticles for Programmable Dual Drug Release by Emulsion Electrospraying

Porous Hydrophilic Core/hydrophobic Shell Nanoparticles for Particle Size and Drug Release Control

Novel PEG-graft-PLA Nanoparticles with the Potential for Encapsulation and Controlled Release of Hydrophobic and Hydrophilic Medications in Aqueous Medium

One-step fabrication of core-shell structured alginate-PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs.

Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery